Verena I. Gaidzik

Genomic Classification and Prognosis in Acute Myeloid Leukemia

Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger et al. · New England Journal of Medicine · 2016 · 4.4K citations · Full text

Life Sciences, Genetics, Oncology +14

<i>IDH1</i>and<i>IDH2</i>Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With<i>NPM1</i>Mutation Without<i>FLT3</i>Internal Tandem Duplication

Peter Paschka, Richard F. Schlenk, Verena I. Gaidzik et al. · Journal of Clinical Oncology · 2010 · 791 citations

Life Sciences, Genetics, Hematology +16

Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

Rongqing Pan, Leah J. Hogdal, Juliana M. Benito et al. · Cancer Discovery · 2013 · 735 citations · Full text

Life Sciences, Oncology, Pharmacology +17

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

Frank G. Rücker, Richard F. Schlenk, Lars Bullinger et al. · Blood · 2011 · 678 citations · Full text

Life Sciences, Genetics, Oncology +17

<i>RUNX1</i>Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk et al. · Journal of Clinical Oncology · 2011 · 450 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16